NEW YORK (GenomeWeb News) — Metabolon said yesterday that the US Army Medical Research Institute of Infectious Diseases will use its metabolomics platform to study the effects of the AVA anthrax vaccine in humans.
 
Metabolon's chief science officer Mike Milburn said the collaboration on the FDA-approved vaccine is the “first large-scale metabolomics study of human subjects given a vaccine.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.